Roxithromycin

Specifications

80214-83-1CAS Number

617-007-5EC Number

(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethylIUPAC Name

C41H76N2O15Chemical Formula

837 g/molMolecular Weight

roxithromycin; Rulide; 80214-83-1; Rulid; RU 28965; RU 965; RU-965; DTXSID8041117; NSC-758443; 21KOF230FA; CHEBI:48935; RU-28965; DTXCID6021117; CHEBI:48844; (9E)-erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime), (9E)-; Infectoroxit; Erythromycin, 9-[O-[(2-methoxyethoxy)methyl]oxime], (9E)-; Roxi-paed 1A Pharma; Roxitromycin; Roxitromycine; RU965; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-((2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-10-(2,4,7-trioxa-1-azaoctan-1-ylidene)-1-oxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-10-(2,4,7-trioxa-1-azaoctan-1-ylidene)-1-oxacyclotetradecan-2-one; RU28965; RefChem:883874; J01FA06; 9-(2',5'-Dioxahexyloxyimino)erythromycin; (9E)-Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime); (2R,3S,4S,5R,6R,8R,9E,10R,11R,12S,13R)-5-(3,4,6-Trideoxy-3-dimethylamino-beta-D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-6,11,12-trihydroxy-9-(2-methoxyethoxy)methoxyimino-2,4,6,8,10,12-hexamethylpentadecan-13-olide; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-((2S,3R,4S,6R)-4-d-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one; 617-007-5; Roxithromycine; Roxithromycinum; Roxitromicina; Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime); (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one; C41H76N2O15; 9-(O-((2-Methoxyethoxy)methyl)oxime)erythromycin; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(((2-methoxyethoxy)methoxy)imino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; Erythromycin 9-[O-[(2-methoxyethoxy)methyl]oxime]; (E)-roxithromycin; Roxithromycine [French]; Roxithromycinum [Latin]; Roxitromicina [Spanish]; Erythromycin, 9-[O-[(2-methoxyethoxy)methyl]oxime], (9E)- (9CI); (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one; Rulide (TN); 9-[O-[(2-Methoxyethoxy)methyl]oxime]erythromycin; SR-05000001850; UNII-21KOF230FA; CCRIS 3461; Cirumycin;; Macrosil;; Rotramin;; Roxitrol;; Abbotic;; Azuril;; Roxithromycin CRS; NCGC00016942-01; NCGC00182077-02; Roxithromycin [USAN:INN:BAN:JAN]; CAS-80214-83-1; RC2952; BRN 4286925; Spectrum5_001058; ROXITHROMYCIN [MI]; Antibiotic RU 28965;; ROXITHROMYCIN [INN]; ROXITHROMYCIN [JAN]; ROXITHROMYCIN [USAN]; SCHEMBL65985; BSPBio_002717; ROXITHROMYCIN [MART.]; SPECTRUM1503276; 9-[O-(2-methoxyethoxymethyl)-oxime] of erythromycin; Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime); ROXITHROMYCIN [WHO-DD]; GTPL1465; orb1223972; CHEMBL1214185; HMS501D04; MSK7712; GLXC-21025; HMS1922O19; HMS2093C11; HMS3714L09; Pharmakon1600-01503276; Roxithromycin (JP18/USAN/INN); ROXITHROMYCIN [EP IMPURITY]; HY-B0435; ROXITHROMYCIN [EP MONOGRAPH]; Tox21_110697; Tox21_113150; Tox21_301835; BDBM50248154; CCG-39329; MSK7712-100M; NSC758443; AKOS015969730; MSK7712-1000M; AR27766; DB00778; NSC 758443; IDI1_000382; Roxithromycin for system suitability CRS; NCGC00178510-01; NCGC00255408-01; SY077440; Roxithromycin 100 |Ig/mL in Acetonitrile; SBI-0051809.P002; NS00000206; R5992; Roxithromycin 100 microg/mL in Acetonitrile; Roxithromycin Solution in Methanol, 100ug/mL; D01710; Roxithromycin Solution in Methanol, 1000ug/mL; AB00052342_02; Q424037; SR-05000001850-1; SR-05000001850-2; BRD-K38684403-001-03-9; BRD-K38684403-001-04-7; BRD-K38684403-001-05-4; 9-[O-[(2-Methoxyethoxy)methyl]oxime]erythromycin, (9E)-; rahydro-2H-pyran-2-yl)oxy)-10-(((2-methoxyethoxy)methox; tetrahydro-2H-pyran-2-yl)oxy)-10-(((2-methoxyethoxy)met; (E)-ERYTHROMYCIN-9-(O-((2-METHOXYETHOXY)METHYL)OXIME); ERYTHROMYCIN 9-(E)-(O-((2-METHOXYETHOXY)METHYL)OXIME); ERYTHROMYCIN A, 9-(O-(2-METHOXYETHOXYMETHYL)-OXIME); hoxy)imino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; y)imino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-10-{[(2-methoxyethoxy)methoxy]imino}-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-10-{[(2-methoxyethoxy)methoxy]imino}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione 10-{O-[(2-methoxyethoxy)methyl]oxime} (non-preferred name); (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-4-((2,6DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-14-ETHYL-7,12,13-TRIHYDROXY-10-((E)((2-METHOXYETHOXY)METHOXY)IMINO)-3,5,7,9,11,13HEXAMETHYL-6-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLOHEXOPYRANOSYL)OXY)OXACYCLOTETRADECAN-2-ONE; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-10-{[(2-methoxyethoxy)methoxy]imino}-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(((2-methoxyethoxy)met; (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltet; RoxythromycinSynonyms